C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2002
11/21/2002	US20020173534 Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
11/21/2002	US20020173533 Induce apoptosis; dissolving in critical fluid; separation
11/21/2002	US20020173532 Induce apoptosis
11/21/2002	US20020173527 Tumor necrosis factor antagonist; antiinflammatory agents
11/21/2002	US20020173518 Anticoagulant in mammls
11/21/2002	US20020173492 Novel pesticides
11/21/2002	US20020173425 Herbicides
11/21/2002	CA2447305A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors
11/21/2002	CA2446980A1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
11/21/2002	CA2445477A1 Antitumor agents
11/21/2002	CA2445003A1 Diarylurea derivatives useful as anti-inflammatory agents
11/20/2002	EP1258480A1 Pharmaceutical use of N-Carbamoylazole derivatives
11/20/2002	EP1258252A1 Integrin expression inhibitors
11/20/2002	EP1257547A1 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
11/20/2002	EP1257546A1 Kinase inhibitors
11/20/2002	EP1257544A2 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage
11/20/2002	EP1257543A1 Pyridinylimidazoles
11/20/2002	EP1257539A2 Amino pyrazole derivatives useful for the treatment of obesity and other disorders
11/20/2002	EP1187832B1 Amino heterocycles useful as pharmaceutical agents
11/20/2002	EP1007522B1 2- 4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]piperazin-1-yl -5-fluoropyrimidine, its preparation and therapeutic use
11/20/2002	EP0929530B1 Quinazoline derivatives and pharmaceutical compositions containing them
11/20/2002	EP0925302B1 Palladium catalyzed indolization
11/20/2002	EP0826673B1 Acetamide derivatives, process for producing the same, and medicinal composition containing the same
11/20/2002	EP0721453B1 Process for the preparation of n-methyl-3-(1-methyl-4-piperidinyl)-14-indole-5-ethanesulphonamide
11/20/2002	CN1094491C 2-{4-[4-(4,5-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimiding, preparation and use thereof
11/19/2002	US6482956 Endothelin receptor antagonists
11/19/2002	US6482955 Organometallic reagent reacted with an activated carboxylic acid to produce a ketone reacted with carbon disulfide and dihalomethane, further reacting the dithietane product with a secondary amine, and condensing the thioamide with hydrazine
11/19/2002	US6482951 Isoindolin-1-one glucokinase activators
11/19/2002	US6482949 Colormetric sensor compositions and methods
11/19/2002	US6482920 Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
11/19/2002	US6482848 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
11/19/2002	US6482847 3-(1-methyl-3-indolyl)-4-(1-methyl-6-nitro-3-indolyl)-1h -pyrrole-2,5-dione anticarcinogenic agents
11/19/2002	US6482834 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
11/19/2002	US6482832 Heterocyclically substituted amides, their production and their use
11/19/2002	US6482773 Pyridazin-3-one derivatives, their use, and intermediates for their production
11/19/2002	CA2138308C Preparation of hexahydroazepinones and hexahydroazepinoles
11/18/2002	WO2001087855A1 Triazole derivatives
11/14/2002	WO2002090355A1 N-aroyl cyclic amines
11/14/2002	WO2002090348A1 Sulfonamides
11/14/2002	WO2002090347A1 Amide compounds
11/14/2002	WO2002090335A1 Azole compounds, process for preparation of the same and use thereof
11/14/2002	WO2002089811A1 Benzo[d]azepine derivatives as 5-ht6 receptor antagonists.
11/14/2002	WO2002089804A1 Alpha-2-adrenergic agonist/fatty acid compositions
11/14/2002	WO2002089793A1 Sulfonamides
11/14/2002	WO2002089792A1 Sulfonamides
11/14/2002	WO2002081453A8 Thiohydantoins and use thereof for treating diabetes
11/14/2002	WO2002074764A3 Piperazine derivatives and their use as 5-ht1b ligands
11/14/2002	WO2002064550A8 Glucocorticoid receptor modulators
11/14/2002	US20020169322 Use of N-alkylamino-heterocylic compounds for the treatment of migraine
11/14/2002	US20020169313 Of carbonyl compounds with secondary amines in the presence of a water scavenger, preferably trifluoroacetic acid; preparation of imidazole-containing benzodiazepines, which are inhibitors of farnesyl protein transferase
11/14/2002	US20020169200 Antitumor, antiinflammatory and antiarthritic agents, treating metastasis, restenosis, osteoporosis, inflammation, macular degeneration, and diabetic retinopathy
11/14/2002	US20020169180 Quinoline or quinazoline derivatives; antitumor agent, treating respiratory tract and gastrointestinal disorders
11/14/2002	US20020169165 Substituted bicyclic derivatives for the treatment of abnormal cell growth
11/14/2002	US20020169159 An acetamide derivative is useful for treatment of inflammatory and immune conditions and diseases; modulates the expressin and/or function of a chemokine receptor
11/14/2002	US20020169113 Orally available peptidic thrombin inhibitors
11/14/2002	CA2446396A1 N-aroyl cyclic amines
11/14/2002	CA2446387A1 Azole compound, process for producing the same and use thereof
11/14/2002	CA2446365A1 Sulfonamides
11/14/2002	CA2446234A1 Alpha-2-adrenergic agonist/fatty acid compositions
11/13/2002	EP1256576A1 Fused imidazolium derivatives
11/13/2002	EP1256574A1 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
11/13/2002	EP1255753A2 Prodigiosin-derivatives as neoplastic and anti-viral agents
11/13/2002	EP1255752A2 Pyrrole substituted 2-indolinone protein kinase inhibitors
11/13/2002	EP1255751A2 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b or v1b and v1a arginine-vasopressin receptors
11/13/2002	EP1255740A2 Substituted arylpyrazines
11/13/2002	EP1255739A1 3-aminoquinazolin-2,4-dione antibacterial agents
11/13/2002	EP1255738A2 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
11/13/2002	EP1255734A1 Isatine derivatives with neurotrophic activity
11/13/2002	EP1255536A2 Indolinone derivatives for modulation of c-kit tyrosine protein kinase
11/13/2002	EP1068199B1 N-aryloxyethyl-indoly-alkylamines for the treatment of depression
11/13/2002	CN1379775A Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
11/13/2002	CN1379766A Benzoic acid derivatives for treatment of diabetes mellitus
11/13/2002	CN1379765A Benzodiazepine derivatives usable as parental metabolic glutamate receptor antagonist
11/13/2002	CN1379764A Benzodiazepine derivatives
11/13/2002	CN1379762A Beta substituted metalloprotease inhibitors
11/13/2002	CN1379668A 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents
11/12/2002	US6479531 Gastrin and cholecystokinin receptor ligands
11/12/2002	US6479508 Viral polymerase inhibitors
11/12/2002	US6479505 6-arylphenanthridines with PDE-IV inhibiting activity
11/12/2002	US6479500 Alleviating side effects caused by use of an anti-tumor agent comprising administering 5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1h,3h)-pyrimidin edione
11/12/2002	US6479494 Arylalkanoyl pyridazines
11/12/2002	US6479492 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/12/2002	US6479490 Treatment of diseases characterized by excess th2 cytokines and/ or an excess ige production.
11/12/2002	US6479480 1h-indole derivatives bearing an optionally substituted phenyl moiety at the 2-position of the indole ring system and a methylene-linked heterocyclic moiety at the 3-position of the indole ring system; schizophrenia treatment
11/12/2002	US6479479 Azetidine derivatives, their preparation and pharmaceutical compositions containing them
11/12/2002	US6479435 Or diaryl sulfides, 1-(4-chloro-2-fluoro-5-(2-pyrimidyloxy)phenyl)-4-difluoromethy l-3-methyl-1,4-dihydro-1,2,4-triazolin-5-one for example
11/12/2002	CA2324959C Phthalimido compounds as intermediates for producing substance p receptor antagonists
11/12/2002	CA2246839C Pharmaceutical compositions containing ampa receptor antagonists for treating dyskineslas associated with dopamine agonist therapy
11/12/2002	CA2144294C (pyrrolidinyl)phenyl carbamates and intermediate compounds, processes for their preparation and their use as medicaments
11/07/2002	WO2002088115A1 Novel sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same
11/07/2002	WO2002088114A2 Heteroaryl ofefinic azacyclic and heteroaryl acetylenic azacyclic compounds for the treatment of cns disorders
11/07/2002	WO2002088113A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
11/07/2002	WO2002088112A1 Heterocyclic compound and antitumor agent containing the same as active ingredient
11/07/2002	WO2002088110A1 Quinoline derivative having azolyl group and quinazoline derivative
11/07/2002	WO2002088108A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
11/07/2002	WO2002088107A1 Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof
11/07/2002	WO2002088101A2 Inhibitors of bace
11/07/2002	WO2002088097A1 Triazole-derived kinase inhibitors and uses thereof
11/07/2002	WO2002088095A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002	WO2002088094A1 2-iminoimidazole derivatives (1)

1 ... 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 ... 626